Latest Insider Transactions at Cytokinetics Inc (CYTK)
This section provides a real-time view of insider transactions for Cytokinetics Inc (CYTK). The data is sourced from Form 4 filings with the SEC, which are filed by insiders of CYTOKINETICS INC to disclose their transactions in the company's securities. By reviewing this information, investors can gain insights into the trading activity of CYTOKINETICS INC's insiders and make more informed investment decisions.
Insider Transaction List
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Jan 17
2023
|
Robert I Blum President & CEO |
BUY
Exercise of conversion of derivative security
|
Direct |
10,000
+2.35%
|
$90,000
$9.65 P/Share
|
|
Jan 12
2023
|
Fady Ibraham Malik EVP Research & Development |
SELL
Open market or private sale
|
Direct |
4,000
-2.49%
|
$160,000
$40.47 P/Share
|
|
Jan 04
2023
|
Robert I Blum President & CEO |
SELL
Open market or private sale
|
Direct |
10,000
-2.4%
|
$440,000
$44.24 P/Share
|
|
Jan 04
2023
|
Robert I Blum President & CEO |
BUY
Exercise of conversion of derivative security
|
Direct |
10,000
+2.35%
|
$90,000
$9.65 P/Share
|
|
Jan 03
2023
|
Wendall Wierenga Director |
BUY
Grant, award, or other acquisition
|
Direct |
253
+1.98%
|
$11,132
$44.35 P/Share
|
|
Jan 03
2023
|
Nancy Wysenski Director |
BUY
Grant, award, or other acquisition
|
Direct |
126
+1.08%
|
$5,544
$44.35 P/Share
|
|
Jan 03
2023
|
Robert Arthur Harrington Director |
BUY
Grant, award, or other acquisition
|
Direct |
253
+4.6%
|
$11,132
$44.35 P/Share
|
|
Jan 03
2023
|
Edward M. Md Kaye Director |
BUY
Grant, award, or other acquisition
|
Direct |
253
+1.9%
|
$11,132
$44.35 P/Share
|
|
Jan 03
2023
|
Sandford D Smith Director |
BUY
Grant, award, or other acquisition
|
Direct |
253
+1.98%
|
$11,132
$44.35 P/Share
|
|
Jan 03
2023
|
John T Henderson Director |
BUY
Grant, award, or other acquisition
|
Direct |
450
+1.78%
|
$19,800
$44.35 P/Share
|
|
Dec 21
2022
|
Robert I Blum President & CEO |
SELL
Open market or private sale
|
Direct |
10,000
-2.4%
|
$430,000
$43.92 P/Share
|
|
Dec 21
2022
|
Robert I Blum President & CEO |
BUY
Exercise of conversion of derivative security
|
Direct |
10,000
+2.35%
|
$90,000
$9.65 P/Share
|
|
Dec 08
2022
|
Fady Ibraham Malik EVP Research & Development |
SELL
Open market or private sale
|
Direct |
4,000
-2.43%
|
$144,000
$36.28 P/Share
|
|
Dec 05
2022
|
Robert I Blum President & CEO |
SELL
Open market or private sale
|
Direct |
10,000
-2.4%
|
$390,000
$39.3 P/Share
|
|
Dec 05
2022
|
Robert I Blum President & CEO |
BUY
Exercise of conversion of derivative security
|
Direct |
10,000
+2.35%
|
$90,000
$9.65 P/Share
|
|
Nov 21
2022
|
Robert I Blum President & CEO |
SELL
Open market or private sale
|
Direct |
10,000
-2.4%
|
$400,000
$40.89 P/Share
|
|
Nov 21
2022
|
Robert I Blum President & CEO |
BUY
Exercise of conversion of derivative security
|
Direct |
10,000
+2.35%
|
$90,000
$9.65 P/Share
|
|
Nov 14
2022
|
Robert Wong VP, Chief Accounting Officer |
SELL
Open market or private sale
|
Direct |
2,100
-6.43%
|
$84,000
$40.68 P/Share
|
|
Nov 10
2022
|
Fady Ibraham Malik EVP Research & Development |
SELL
Open market or private sale
|
Direct |
4,000
-2.38%
|
$152,000
$38.04 P/Share
|
|
Nov 02
2022
|
Robert I Blum President & CEO |
SELL
Open market or private sale
|
Direct |
10,000
-1.21%
|
$420,000
$42.17 P/Share
|
|
Nov 02
2022
|
Robert I Blum President & CEO |
BUY
Exercise of conversion of derivative security
|
Direct |
10,000
+1.18%
|
$80,000
$8.81 P/Share
|
|
Oct 19
2022
|
Robert I Blum President & CEO |
SELL
Open market or private sale
|
Direct |
10,000
-2.4%
|
$470,000
$47.86 P/Share
|
|
Oct 19
2022
|
Robert I Blum President & CEO |
BUY
Exercise of conversion of derivative security
|
Direct |
10,000
+2.35%
|
$70,000
$7.96 P/Share
|
|
Oct 13
2022
|
Fady Ibraham Malik EVP Research & Development |
SELL
Open market or private sale
|
Direct |
21,513
-11.33%
|
$1,011,111
$47.28 P/Share
|
|
Oct 13
2022
|
Fady Ibraham Malik EVP Research & Development |
BUY
Exercise of conversion of derivative security
|
Direct |
21,513
+10.18%
|
$193,617
$9.65 P/Share
|
|
Oct 03
2022
|
Nancy Wysenski Director |
BUY
Grant, award, or other acquisition
|
Direct |
110
+0.96%
|
$5,610
$51.11 P/Share
|
|
Oct 03
2022
|
Wendall Wierenga Director |
BUY
Grant, award, or other acquisition
|
Direct |
110
+0.89%
|
$5,610
$51.11 P/Share
|
|
Oct 03
2022
|
Sandford D Smith Director |
BUY
Grant, award, or other acquisition
|
Direct |
110
+0.89%
|
$5,610
$51.11 P/Share
|
|
Oct 03
2022
|
Edward M. Md Kaye Director |
BUY
Grant, award, or other acquisition
|
Direct |
220
+1.69%
|
$11,220
$51.11 P/Share
|
|
Oct 03
2022
|
John T Henderson Director |
BUY
Grant, award, or other acquisition
|
Direct |
391
+1.57%
|
$19,941
$51.11 P/Share
|
|
Oct 03
2022
|
Robert I Blum President & CEO |
SELL
Open market or private sale
|
Direct |
10,000
-2.4%
|
$500,000
$50.4 P/Share
|
|
Oct 03
2022
|
Robert I Blum President & CEO |
BUY
Exercise of conversion of derivative security
|
Direct |
10,000
+2.35%
|
$70,000
$7.96 P/Share
|
|
Oct 03
2022
|
Muna Bhanji Director |
BUY
Grant, award, or other acquisition
|
Direct |
220
+1.96%
|
$11,220
$51.11 P/Share
|
|
Sep 19
2022
|
Robert I Blum President & CEO |
SELL
Open market or private sale
|
Direct |
10,000
-2.4%
|
$510,000
$51.42 P/Share
|
|
Sep 19
2022
|
Robert I Blum President & CEO |
BUY
Exercise of conversion of derivative security
|
Direct |
10,000
+2.35%
|
$70,000
$7.96 P/Share
|
|
Sep 12
2022
|
John T Henderson Director |
SELL
Open market or private sale
|
Direct |
21,759
-23.17%
|
$1,174,986
$54.94 P/Share
|
|
Sep 12
2022
|
John T Henderson Director |
BUY
Exercise of conversion of derivative security
|
Direct |
21,759
+18.81%
|
$87,036
$4.02 P/Share
|
|
Sep 08
2022
|
Fady Ibraham Malik EVP Research & Development |
SELL
Open market or private sale
|
Direct |
21,500
-11.33%
|
$1,096,500
$51.88 P/Share
|
|
Sep 08
2022
|
Fady Ibraham Malik EVP Research & Development |
BUY
Exercise of conversion of derivative security
|
Direct |
21,500
+10.17%
|
$193,500
$9.65 P/Share
|
|
Sep 07
2022
|
Robert I Blum President & CEO |
SELL
Open market or private sale
|
Direct |
10,000
-2.4%
|
$490,000
$49.11 P/Share
|
|
Sep 07
2022
|
Robert I Blum President & CEO |
BUY
Exercise of conversion of derivative security
|
Direct |
10,000
+2.35%
|
$70,000
$7.96 P/Share
|
|
Sep 02
2022
|
Sandford D Smith Director |
SELL
Open market or private sale
|
Direct |
11,369
-48.3%
|
$602,557
$53.97 P/Share
|
|
Sep 02
2022
|
Sandford D Smith Director |
BUY
Exercise of conversion of derivative security
|
Direct |
11,369
+15.98%
|
$272,856
$24.3 P/Share
|
|
Sep 01
2022
|
B Lynne Parshall Director |
SELL
Open market or private sale
|
Direct |
30,296
-75.18%
|
$1,575,392
$52.79 P/Share
|
|
Sep 01
2022
|
B Lynne Parshall Director |
BUY
Exercise of conversion of derivative security
|
Direct |
30,296
+24.26%
|
$242,368
$8.34 P/Share
|
|
Sep 01
2022
|
Wendall Wierenga Director |
SELL
Open market or private sale
|
Direct |
4,166
-25.5%
|
$216,632
$52.79 P/Share
|
|
Sep 01
2022
|
Wendall Wierenga Director |
BUY
Exercise of conversion of derivative security
|
Direct |
4,166
+20.32%
|
$24,996
$6.78 P/Share
|
|
Sep 01
2022
|
Santo J Costa Director |
SELL
Open market or private sale
|
Direct |
15,000
-60.0%
|
$780,000
$52.79 P/Share
|
|
Sep 01
2022
|
Santo J Costa Director |
BUY
Exercise of conversion of derivative security
|
Direct |
15,000
+26.79%
|
$150,000
$10.07 P/Share
|
|
Aug 17
2022
|
Robert I Blum President & CEO |
SELL
Open market or private sale
|
Direct |
10,000
-2.39%
|
$500,000
$50.11 P/Share
|